Gotowe bibliografie tematyczne / Cancer patients

Gotowa bibliografia na temat „Cancer patients”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 28 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cancer patients”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Cancer patients"

1

Shams, Salima. "ENSEIGNEMENT AUX PATIENTS : Counselling pour les patients atteints d’un cancer de la bouche". Canadian Oncology Nursing Journal 34, nr 2 (30.04.2024): 238–44. http://dx.doi.org/10.5737/23688076342238.

Pełny tekst źródła
Streszczenie:
L’objectif du présent article est de résumer les aspects centraux des soins aux patients atteints d’un cancer avancé de la bouche avec métastases dans la région de la tête et du cou. Ces patients sont traités par approche multimodale. L’intervention chirurgicale limite leur capacité de parler et d’avaler, tandis que la chimiothérapie et la radiothérapie peuvent entraîner nausées et vomissements, diarrhée, mucite, cystite, déshydratation, néphrotoxicité, dermatite, dépression médullaire et carences alimentaires entraînant une perte de poids. Il est possible de contrer ces effets toxiques à l’aide de mesures d’autosoins. Dans le cadre de leurs interventions d’enseignement, les infirmières en oncologie pourraient transmettre aux patients et aux familles les connaissances nécessaires à l’application de ces mesures d’autosoins. Mots-clés : cancer avancé de la bouche, cancer de la tête et du cou, counselling, mesures d’autosoins
Style APA, Harvard, Vancouver, ISO itp.
2

Sartip Tahir, Bahez, i Bahar Nasradeen Majeed. "QUALITY OF LIFE OF PEDIATRIC CANCER PATIENTS UNDERGOING CANCER THERAPY IN SULAIMANI CITY, IRAQ (PATIENT’S REPORT)". Journal of Sulaimani Medical College 11, nr 3 (21.09.2021): 359–70. http://dx.doi.org/10.17656/jsmc.10321.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Rajvi, Patel, Park Jennifer, Shah Ankit i Wasif Saif Muhammad. "COVID-19 and Cancer Patients". Cancer Medicine Journal 3, nr 1 (30.06.2020): 40–48. http://dx.doi.org/10.46619/cmj.2020.3-1019.

Pełny tekst źródła
Streszczenie:
COVID-19 has now been declared a global pandemic with evolving incidence rates and fatalities. It is important to identify vulnerable populations who will be impacted most by this pandemic leading to higher mortality rates compared to the general healthy population. Although older patients and patients with co-morbidities fall into this vulnerable group, patients with hematologic and oncologic malignancies on active cytotoxic treatments are at even greater risk as they are both myelosuppressed and immunosuppressed. In addition to following the universal guidelines recommended by the Centers for Disease Control (CDC), it is important to also institute guidelines for cancer centers to help protect this vulnerable population. We review the current data, risks, and recommendations for COVID-19 in cancer patients.
Style APA, Harvard, Vancouver, ISO itp.
4

Sato, Akira, Eiji Aramaki, Yumiko Shimamoto, Shiro Tanaka i Koji Kawakami. "Blog Posting After Lung Cancer Notification: Content Analysis of Blogs Written by Patients or Their Families". JMIR Cancer 1, nr 1 (18.05.2015): e5. http://dx.doi.org/10.2196/cancer.3883.

Pełny tekst źródła
Streszczenie:
Background The advent and spread of the Internet has changed the way societies communicate. A portion of information on the Internet may constitute an important source of information concerning the experiences and thoughts of patients and their families. Patients and their families use blogs to obtain updated information, search for alternative treatments, facilitate communication with other patients, and receive emotional support. However, much of this information has yet to be actively utilized by health care professionals. Objective We analyzed health-related information in blogs from Japan, focusing on the feelings and satisfaction levels of lung cancer patients or their family members after being notified of their disease. Methods We collected 100 blogs written in Japanese by patients (or their families) who had been diagnosed with lung cancer by a physician. These 100 blogs posts were searchable between June 1 and June 30, 2013. We focused on blog posts that addressed the lung cancer notification event. We analyzed the data using two different approaches (Analysis A and Analysis B). Analysis A was blog content analysis in which we analyzed the content addressing the disease notification event in each blog. Analysis B was patient's dissatisfaction and anxiety analysis. Detailed blog content regarding patient's dissatisfaction and anxiety at the individual sentence level was coded and analyzed. Results The 100 blog posts were written by 48 men, 46 women, and 6 persons whose sex was undisclosed. The average age of the blog authors was 52.4 years. With regard to cancer staging, there were 5 patients at Stage I, 3 patients at Stage II, 14 patients at Stage III, 21 patients at Stage IV, and 57 patients without a disclosed cancer stage. The results of Analysis A showed that the proportion of patients who were dissatisfied with the level of health care exceeded that of satisfied patients (22% vs 8%). From the 2499 sentences in the 100 blog posts analyzed, we identified expressions of dissatisfaction and anxiety in 495 sentences. Our results showed that there were substantially more posts concerning “Way of living, reasons for living, set of values” and “Relationships with medical staff (own hospital)” than in previous studies (Analysis B). Conclusions This study provides insight into the feelings of dissatisfaction and anxieties held by lung cancer patients and their families, including those regarding the “Way of living, reasons for living, set of values” and “Relationship with medical staff (own hospital),” which were inaccessible in previous survey analyses. When comparing information obtained from patients’ voluntary records and those from previous surveys conducted by health care institutions, it is likely that the former would be more indicative of patients’ actual opinions and feelings. Therefore, it is important to utilize such records as an information resource.
Style APA, Harvard, Vancouver, ISO itp.
5

KG, Nayana, Panayappan L, Krishna Kumar K i Jayaprakash K. "Thromboprophylaxis in Cancer Patients-A Review". Scholars Journal of Applied Medical Sciences 4, nr 6 (czerwiec 2016): 1953–55. http://dx.doi.org/10.21276/sjams.2016.4.6.17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Tomilová, Marina, i Kristýna Frühaufová. "Female fertility preservation in cancer patients". Česká gynekologie 87, nr 5 (24.10.2022): 356–61. http://dx.doi.org/10.48095/cccg2022356.

Pełny tekst źródła
Streszczenie:
Fertility preservation in cancer patients or oncofertility is a relatively new trend in modern medicine. In patients with unfulfilled reproductive plans, the possibility of starting a family is one of the key parameters of quality of life after overcoming a cancer. Guidelines have existed since 2013 and in 2020 the European Society of Human Reproduction and Embryology has also published a guideline, but the main problem of their application in clinical practice is the lack of information for both patients and, unfortunately, professionals, as well as the high cost of treatment. From 2022, health insurance companies in the Czech Republic partially cover the expenses for fertility preservation treatment for cancer patients. The possibilities of oncofertility are based, on the one hand, on improving the results of oncological treatment, on the other hand, on the development of reproductive technologies. Thanks to progress in treatment, up to 80% of pediatric oncology patients survive into adulthood, but chemotherapy, especially highly eff ective alkylating agents, is associated with a high risk of impaired fertility. This article overviewed modern global trends of fertility preservation in women undergoing cancer treatment based on an analysis of the English-language literature over the past 5 years. Key words: oncofertility – fertility preservation – oocyte cryopreservation – embryo cryopreservation – ovarian tissue cryopreservation – oocyte in vitro maturation – gonadotropin-releasing hormone agonists
Style APA, Harvard, Vancouver, ISO itp.
7

Hussain, Dr Hidayath. "Pulmonary Tuberculosis in Breast Cancer Patients". Journal of Medical Science and clinical Research 12, nr 01 (31.01.2024): 57–60. http://dx.doi.org/10.18535/jmscr/v12i01.09.

Pełny tekst źródła
Streszczenie:
Background ● The Population with malignancy is growing worldwide. ● TB remains most common infectious disease worldwide that leads to high mortality. ● The relationship between TB and cancer is of dual nature. Patients with malignant diseases are at increased risk for diseases caused by mycobacteria. Patients with depressed cellular immunity such as those who have cancer, transplant patients and patients on immunosuppressive therapy are at particular risk. ● The risk of TB in patients with malignancy is due to immunosuppression from the cancer itself or from the chemotherapy. ● The incidence of pulmonary TB has been therefore reportedly increasing in patients with cancer in both pulmonary and non pulmonary cancers. ● The incidence of TB in cancer patients is also increasing annually from 3% to 23 % in 2022. ● Patients with diabetes, HIV, and cancer patients and persons on corticosteroid frequently present with lower zone tuberculosis. ● It affects females more commonly as compared to males and tuberculosis should be looked in females with lower lung field lesions. ● Cough is the most frequent presentation of lower zone TB as compared to upper zone TB. ● In immunocompromised patients, isolated lower lung field were involved in almost 23.3% patients.
Style APA, Harvard, Vancouver, ISO itp.
8

Ishaq, Aliya. "Age Related Disparities in Colorectal Cancer Patients". Journal of Clinical and Laboratory Research 3, nr 3 (11.09.2021): 01–04. http://dx.doi.org/10.31579/2768-0487/064.

Pełny tekst źródła
Streszczenie:
Background: There is an evident change in the colorectal cancer demographic over the period. This change is more marked in the age distribution and location of the tumor. It has practical implications, in regards to develop cancer awareness programs and screening protocols. Keeping in view that Pakistan is one of the countries with a high number of the young population this study is carried out to make a comparative analysis of this trend in our population. Material and methods: Colorectal cancer patients presented in Sindh Institute of urology and transplantation from January 2011 till December 2020 was reviewed retrospectively. All patients were divided into two groups, Group A young age population and Group B old age population. Subgroup analysis of study period was performed to check the progressive change in the trend of stage and clinical characteristics of colorectal cancer patients. Data reviewed from the patient’s files and collected as per Proforma requirement. Result: Total of 612 patients with colorectal cancer presented between 2011 till 2020.Among these patients 243 (39.7%) presented between January 2011 till December 2015. Patients age 50 years and younger were 410 (66.8%). Results showed a statistically significant association between and patient’s age and location of tumor such that left-sided colonic cancer and rectal cancer were more common in the young population. Subgroup analysis according to the study period showed that there is a change in the trend of disease presentation. Right-sided colonic cancer presentation decreased in the younger population over the period while simultaneously left-sided colonic cancer and rectal cancer presentation increased. Conclusion: The incidence of left-sided colonic and rectal cancer has been increased in the younger population over the specified period while there was no association between right-sided colon cancer and age noticed.
Style APA, Harvard, Vancouver, ISO itp.
9

Pirbudak, Lütfiye. "Characteristics of pain in lung cancer patients". Turkish Journal of Thoracic and Cardiovascular Surgery 21, nr 4 (7.10.2013): 995–99. http://dx.doi.org/10.5606/tgkdc.dergisi.2013.7211.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

An, Lawrence C., Lauren Wallner i Matthias Alexander Kirch. "Online Social Engagement by Cancer Patients: A Clinic-Based Patient Survey". JMIR Cancer 2, nr 2 (19.08.2016): e10. http://dx.doi.org/10.2196/cancer.5785.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Cancer patients"

1

凌綽姿 i Cheuk-chi Ling. "Evidence-based pain education programme for cancer patients with pain". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43251365.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Engler, Jennifer [Verfasser]. "Cancer Care and Cancer Patients’ Experiences with Cancer / Jennifer Engler". Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2019. http://d-nb.info/1180994191/34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Dulude, Alexandra. "CANCER PATIENT ATTITUDES TOWARDS INFLUENZA VACCINATION AND THE PREVALENCE OF VACCINATION IN CANCER PATIENTS". Thesis, The University of Arizona, 2015. http://hdl.handle.net/10150/528169.

Pełny tekst źródła
Streszczenie:
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.
Introduction: Thousands of people die from influenza or its complications each year despite the fact that it is one of the few vaccine preventable diseases. Immunocompromised cancer patients are among the most vulnerable to this infection and flu‐related complications, and therefore vaccination is highly recommended in these patients; however, current vaccination rates and attitudes towards vaccination remain unknown. We hypothesize that immunization rates are lower than the 100% recommendation rate, and hope to understand the reasoning behind the discrepancy. The purpose of this study is to assess cancer patient attitudes towards influenza vaccination in an effort to minimize barriers to vaccination and eventually increase vaccination rates in this immunocompromised population. Methods: Cancer patients enrolled in phase I clinical oncology trials at the Virginia G Piper Cancer Center at Scottsdale Healthcare were invited to participate in a voluntary survey. The 15‐item survey consisted of demographic information, knowledge regarding the flu vaccine, vaccination status after cancer diagnosis and while on treatment, and general attitudes towards vaccination. A total of 84 cancer patients completed the survey. Results were stratified by age, gender, education level, and vaccination status. As this was a descriptive study, no statistical analyses were performed. Results: A total of 84 (n=84) advanced cancer patients enrolled in phase I clinical oncology trials completed the survey. Results indicate that although 71% of patients received the vaccine prior to cancer diagnosis, only 58% of patients have received the vaccine since their cancer diagnosis, and only 48% have been vaccinated while on cancer treatment. Of those vaccinated since cancer diagnosis, 94% reported doctor recommendation of the vaccine and most vaccinate to protect themselves from the virus. Of those not vaccinated since cancer diagnosis, only 37% report their doctor recommends the vaccine and the majority avoid vaccination because they believe the vaccine can cause the flu, they do not feel at risk of infection, and they do not believe the vaccine is effective. Conclusion: Our findings suggest that although the CDC strongly recommends influenza vaccination in cancer patients due to the risk of secondary complications and even death in these immunocompromised individuals, vaccination rates remain low. Our data demonstrates that patients who receive a doctor recommendation for the vaccine are more likely to be vaccinated, but not all doctors recommend the vaccine. Furthermore, false information regarding the vaccine, its efficacy, and its ability to cause infection continues to deter patients from vaccination. Together, this information offers profound insight into the cancer patient population and suggests the need for increased physician and patient education regarding the benefits of annual influenza vaccination to improve vaccination rates and decrease influenza infection and complications in the future.
Style APA, Harvard, Vancouver, ISO itp.
4

Crabtree, Melody A. "Self reported effect of patient education on stress and decision making in newly diagnosed cancer patients". Virtual Press, 2000. http://liblink.bsu.edu/uhtbin/catkey/1191706.

Pełny tekst źródła
Streszczenie:
Educational programs covering the technical, treatment and emotional aspects of a cancer diagnosis have been shown to reduce anxiety levels, boost compliance with treatment regimens and improve survival rates. This study was designed to evaluate whether newly diagnosed cancer patients, after reviewing an educational intervention, felt they experienced decreased stress levels and more informed decision making ability. A descriptive, evaluative study was designed. Seventy-five newly diagnosed cancer patient's evaluation forms were examined. Responses were reviewed to see if these patients placed an important versus unimportant value on the individual components of an educational packet. Their responses were tallied and the results showed that an overwhelming majority of the patients felt that the packet components were important in helping them feel decreased stress levels and more informed in their decision making regarding their diagnosis of cancer. It was also determined that the majority of patients felt that the packet components were easy to understand.
Department of Physiology and Health Science
Style APA, Harvard, Vancouver, ISO itp.
5

Matheson, Karen Ann. "Learning needs of cancer patients receiving chemotherapy : patient, nurse, and physician perceptions". Thesis, University of British Columbia, 1987. http://hdl.handle.net/2429/26133.

Pełny tekst źródła
Streszczenie:
Accurate assessment of educational needs is central to the planning of effective patient education programs. Adult learning theory holds that the more agreement that exists in the educator's and the learner's assessment of learning needs, the higher the probability that effective learning will occur. This descriptive survey was carried out to compare the learning needs of cancer patients receiving chemotherapy as perceived by three groups involved in patient education: nurses, physicians, and patients themselves. Using the Assessment of Learning Needs Questionnaire (ALNQ) developed by Lauer, Murphy, and Powers (1982) and demographic data questionnaires developed by the researcher, the perceptions of patients' learning needs held by a convenience sample of 20 lymphoma patients, 24 nurses, and ten physicians were studied. Responses to the rating and ranking scales of the ALNQ were analyzed using nonparametric statistical techniques to determine the existence and location of differences in perceptions among the three groups. General comments about patient education and the ALNQ were gathered from the patient group in an interview setting and from the two care giver groups through responses to two open-ended questionnaire items. Findings revealed that the learning needs of patients undergoing chemotherapy tend to focus on concerns related to the treatment experience, and the knowledge and skills required to cope with the impact of the disease and treatment on their lives. Patients described themselves as most knowledgeable in areas relating to life experience, rather than disease or treatment related areas, and were oriented to survival in their learning needs. The three groups demonstrated considerable similarity in their perceptions of areas problematic to patients and areas in which patients have the most knowledge. However, despite presumed knowledge and expertise in dealing with the concerns of chemotherapy patients, nurses' and physicians' perceptions of patients' learning needs differed from those held by patients. The care givers perceived patients to be more concerned with learning needs related to activities of daily living than patients reported. Implications for nursing practice and education are suggested, and recommendations made for further study.
Applied Science, Faculty of
Nursing, School of
Graduate
Style APA, Harvard, Vancouver, ISO itp.
6

Hellbom, Maria. "Individual Support for Cancer Patients : Effects, Patient Satisfaction and Utilisation". Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2001. http://publications.uu.se/theses/91-554-5183-7/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

OLSSON, MILLA, i CAROLINE ROSELL. "Telemedicine for Lung Cancer Patients". Thesis, KTH, Skolan för datavetenskap och kommunikation (CSC), 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-136951.

Pełny tekst źródła
Streszczenie:
Den svenska sjukvården står idag för ett antal utmaningar om den skall fortsatt kunna erbjuda god service som vårdgivare och vara attraktiv som arbetsgivare. Bland annat diskuteras frågor som förvärrad platsbrist, läkarbrist samt avstånd till specialistsjukvård. På Karolinska Universitetssjukhuset i Solna ligger Radiumhemmet och där behandlas bland annat lungcancerpatienter. Där diskuteras huruvida telemedicin kan vara en möjlig väg för att lösa ovanstående problem. Denna uppsats utreder på vilket sätt telemedicin kan användas på Radiumhemmet för lungcancerpatienter. För att kunna utreda en telemedicinsk lösnings möjligheter på Radiumhemmet genomfördes intervjuer och fokusgrupper med personalen. Externa experter från sjukvården och industri intervjuades och ett besök gjordes på barnsjukhuset Childrens Healthcare of Atlanta, USA, där man har kommit långt i användningen av telemedicin. Det finns delar av verksamheten på Radiumhemmet där telemedicin skulle kunna bidra till att skapa möjligheter till en tätare kontakt mellan patient och vårdpersonal. Detta i syfte att lugna oroliga patienter och hjälpa till med lättare symptombedömningar och på så sätt minska väntetiderna. Genom de undersökningar som utfördes upptäcktes dock även svagheter i en telemedicinsk lösning avsedd för lungcancerpatienter. Patientgruppen ofta är äldre med liten erfarenhet av datorer och sjukdomen är allvarlig. Det krävs personlig kontakt och fysiska undersökningar, men i vilken utsträckning är individuellt. Telemedicin kanske inte kan ses som en absolut lösning för de problem som råder i sjukvården idag när det kommer till lungcancerpatienter, men väl som ett komplement. Om lungcancerpatienter är den optimala målgruppen är ifrågasättbart men att telemedicin kan underlätta i den svenska sjukvården står klart.
Nowadays the health care system in Sweden is faced with several challenges like shortage of space, physicians and long distances to specialized health care. A possible solution for this being discussed at the lung cancer department of Karolinska University 2 Hospital is the use of telemedicine. If implemented it would be part of the followup treatment. The objective of our research is to find out if this technology can help improve the health care. In order to investigate the opportunity for a telemedicine solution, we collected qualitative data from multiple different sources. This included two doctors specialized in lung cancer, and a focus group with nurses from Radiumhemmet. We also conducted interviews with relevant individuals outside the hospital including Nirav Desai who is the Founder and CEO of Hands On Telehealth; furthermore, we visited the Children’s Healthcare of Atlanta based in Atlanta, Georgia where telemedicine is used on a daily basis. Thanks to the carried out research, we have discovered that telemedicine could be used in certain scenarios and contribute towards a more frequent contact between the patient and the medical professionals. Thus, this new technique could help nurses execute lighter symptoms assessment remotely and reduce waiting times. We also discovered some inconveniences in a telemedicine solution designed for lung cancer patients. We personally do not think they are the best target group for such a solution since the patients are mostly the elderly with little computer experience. Also the disease is severe and requires physical examinations where the telemedicine existing today would not improve the care giving. To all intents and purposes, telemedicine might not be the only and ultimate solution for the problems identified within healthcare for lung cancer patients at Radiumhemmet, but it can work well as a supplement. 3
Style APA, Harvard, Vancouver, ISO itp.
8

Fredrix, Elisabeth Wilhelmina Hubertina Maria. "Energy metabolism in cancer patients". Maastricht : Maastricht : Datawyse ; University Library, Maastricht University [Host], 1990. http://arno.unimaas.nl/show.cgi?fid=5567.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Kaur, Jasmine. "Preventative Vaccine for Cancer patients". Thesis, Griffith University, 2022. http://hdl.handle.net/10072/413312.

Pełny tekst źródła
Streszczenie:
Cancer is an age-old disease and a leading cause of mortality worldwide. It starts with the development of abnormal cells that multiply to form tumours and may lead to metastasis causing damage to healthy tissues and organs of the body. Lung cancer is the most common type of cancer with significant morbidity and mortality globally and is of major concern for the society. Decades of research and innovation in the treatment of cancer led to the development of certain conventional therapies such as surgery, radiotherapy, and chemotherapy that are being effectively used. However, these traditional therapies have a disadvantage of destroying healthy cells and tissues in its close proximity, leading to other severe diseases and side effects. Therefore, a much-advanced approach to treat cancer without causing severe side effects became an important area of research. Improvements in the field of anti-cancer therapies led to a strategy to combine traditional treatment approaches to destroy cancer cells. Additionally, treatments such as targeted therapies, hormone therapy, and precision medicine came into existence. Alternatively, the immune system was analysed to determine an effective approach that could control proliferation of cancer cells and cause limited or no damage to other cells. This area of cancer therapeutics, known as immunotherapy, targets the immune system to enhance its ability of recognizing invasive neoplasms. Our immune system in response to an infection immediately activates immune cells, creating a protective immunity for decades. Unfortunately, this immune response often fails when fighting against cancer and is unable to entirely eliminate tumour cells or develop effective immunity. Cancer vaccines, a branch of immunotherapy that has potential therapeutic benefits can build immunity and ultimately lead to prevention from future illness. These have been employed to treat the disease using tumour associated antigens and various adjuvants or immune stimulators and only a few have been in clinical trials. The potential of such cancer vaccines can be exploited to further develop treatment strategies to prevent tumour occurrence and provide long-lasting immunity. This study was designed to primarily explore the potential of a novel immune stimulator, RNA:DNA hybrid and an established TLR9 agonist, CpG 7909. Furthermore, these agonists were used to develop a preventative cancer vaccine in association with a tumour associated carbohydrate antigen, Globo-H to determine whether the novel formulation could improve immune response and trigger antigen presentation in vitro and in vivo. In an in vivo setting, these were also investigated against lung cancer to determine their potential in preventing tumour occurrence. Within this study RAW 264.7 mouse macrophages were initially exposed to varying concentrations of CpG 7909, RNA:DNA hybrid, and Globo-H to determine the optimum dose concentration for the activation of antigen presenting cells by measuring the level of TNF-α secreted in cell culture supernatant. Following dose optimization, the individual agents were combined in a vaccine formulation, sharing the same antigen, where two cell lines, mouse RAW 264.7 macrophages and human monocytic cell line, THP-1 that was differentiated into macrophages and dendritic cells were exposed to the vaccines. TNF-α, IL-12 and IL-6 cytokine response was analysed as measured by ELISA and real-time PCR that were determined to be partially significant in response to the vaccines. The degree of immune response demonstrated by RNA:DNA hybrid-based vaccine (HG-Vax) confirmed that HG-Vax is more effective than CpG 7909-based vaccine (CG-Vax). This response was further analysed in an in vivo model where C57/BL mice were exposed to immune stimulators and vaccines separately for 14- and 28-days before end point termination. Serum was analysed for IL-12 and TNF-α to determine the level of inflammatory response. Even though statistical significance was not achieved in vivo, contrasting observations compared to the in vitro model were exhibited. Secretion of IL-12 in animals confirmed the induction of an anti-tumour immune response. Interestingly, cytokines induced by single dose CG-Vax persisted for a longer period of time in blood in comparison to HG-Vax. However, opposite was true with the booster immunization. In animal model of lung cancer, statistical significance validates that booster immunization with HG-Vax triggers an immune response and upregulates MHC II expression. Unfortunately, CG-Vax did not induce a significant immune response and failed to induce MHC II expression in an in vivo model of lung cancer. Although these findings present RNA:DNA hybrid to be a novel immune stimulator that may have the potential to be used in future cancer vaccinations, further investigation on its immunological potential and mechanism of action remains of need.
Thesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Pharmacy & Med Sci
Griffith Health
Full Text
Style APA, Harvard, Vancouver, ISO itp.
10

Soerjomataram, Isabelle. "Multiple primary cancers in patients with breast ans skin cancer". [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/10779.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Cancer patients"

1

Timmermann, Carsten, i Elizabeth Toon, red. Cancer Patients, Cancer Pathways. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Sue, Bell, i National Cancer Alliance, red. ' Patient-centred cancer services'?: What patients say. Oxford: National Cancer Alliance, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Alliance, National Cancer, red. "Patient-centred cancer services"?: What patients say. Oxford: National Cancer Alliance, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Alliance, National Cancer, red. "Patient-centred cancer services"?: What patients say. Oxford: National Cancer Alliance, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Alliance, National Cancer, red. " Patient-centred cancer services"?: What patients say. Oxford: National Cancer Alliance, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Council on Community Health, Hospital, Institutional, and Medical Affairs. Ad Hoc Committee on Protocol Development. Patients receiving cancer chemotherapy. Chicago, Ill: American Dental Association, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

N, Greene John, red. Infections in cancer patients. New York: Marcel Dekker, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Project, Communication and Education, red. Talking with cancer patients. (Basingstoke): Macmillan, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Sue, Bell, i National Cancer Alliance, red. ' Patient-centred cancer services'?: What patients say : summary version. Oxford: National Cancer Alliance, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Rauh, Stefan, red. Survivorship Care for Cancer Patients. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-78648-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Cancer patients"

1

Fan, Timothy M. "Cancer Patients". W Veterinary Anesthesia and Analgesia, 993–1003. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119421375.ch55.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Villejo, Louise A. "Patient Education for Hispanic Cancer Patients". W Minorities and Cancer, 295–300. New York, NY: Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4612-3630-6_28.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Timmermann, Carsten, i Elizabeth Toon. "Introduction". W Cancer Patients, Cancer Pathways, 1–9. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Zuiderent-Jerak, Teun, Roland Bal i Marc Berg. "Patients and their Problems: Situated Alliances of Patient-Centred Care and Pathway Development". W Cancer Patients, Cancer Pathways, 204–29. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Pickstone, John. "Radicalism, Neoliberalism and Biographical Medicine: Constructions of English Patients and Patient Histories Around 1980 and Now". W Cancer Patients, Cancer Pathways, 230–55. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Baines, Joanna. "Three Stories: Generations of Breast Cancer". W Cancer Patients, Cancer Pathways, 13–35. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Timmermann, Carsten. "Running Out of Options: Surgery, Hope and Progress in the Management of Lung Cancer, 1950s to 1990s". W Cancer Patients, Cancer Pathways, 36–56. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Kutcher, Gerald. "A Case Study in Human Experimentation: The Patient as Subject, Object and Victim". W Cancer Patients, Cancer Pathways, 57–77. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Johnstone, Emm Barnes. "Captain Chemo and Mr Wiggly: Patient Information for Children with Cancer in the Late Twentieth Century". W Cancer Patients, Cancer Pathways, 78–100. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Löwy, Ilana. "Knife, Rays and Women: Controversies about the Uses of Surgery versus Radiotherapy in the Treatment of Female Cancers in France and in the US, 1920–1960". W Cancer Patients, Cancer Pathways, 103–29. London: Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Cancer patients"

1

Rodrigues, Milena de Freitas, Ariane Silva da Rocha, David Siqueira Gonçalves, Maria Paula Curado i Maria Nirvana da Cruz Formiga. "Hereditary cancer syndromes in patients with second primary breast cancer". W Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1067.

Pełny tekst źródła
Streszczenie:
Objective: The objective of this study was to evaluate the presence of hereditary cancer syndromes (HCS) in patients with a diagnosis of two primary breast carcinomas and analyze the frequency of pathogenic variants in high- and moderatepenetrance genes. Methodology: This is a retrospective unicentric cohort study on patients with a diagnosis of two primary breast cancers, diagnosed between January 2000 to December 2020, at A.C. Camargo Cancer Center, Brazil. The association between categorical variables was analyzed by the chi-square test or Fisher’s exact test. For survival curves, the Kaplan-Meier method and log-rank test were used to describe the survival curve differences. Results: Medical records of breast cancer patients were reviewed from 2000 to 2020, and a frequency of 600 patients with two primary breast tumors (metachronous or synchronous) was observed. In total, 190 (31.7%) patients performed genetic testing and 35 (5.8%) patients presented a pathogenic or likely-pathogenic germline variant in cancer predisposing genes. Conclusion: Our results revealed a low rate of genetic testing among patients with two primary breast cancers in a cancer center and a frequency of carrier patients lower than expected.
Style APA, Harvard, Vancouver, ISO itp.
2

Rocha, Ariane Silva da, Gisele Aparecida Fernandes, Cynthia Aparecida Bueno de Toledo Osório, Ruffo de Freitas-Júnior i Maria Paula Curado. "Overall survival in patients with second primary breast cancer". W Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1061.

Pełny tekst źródła
Streszczenie:
Objective: The objective of this study was to analyze the overall survival of patients with second primary synchronous and metachronous breast cancer. Methodology: A retrospective cohort study on women with second primary breast cancer, diagnosed between 2000 and 2015, was conducted. The cases were drawn from the Cancer Hospital registry and classified according to the hospital registry rules for second primary cancers. The second primary breast tumor was defined as synchronous or metachronous according to the diagnosis of the second cancer: ≤6 months of the first tumor and >6 months after the first tumor, respectively (Newman et al. 2001). Survival curves were estimated using the Kaplan-Meier method. Results: A total of 11,922 women with breast cancer were identified between 2000 and 2015. Of these cases, 3.24% (375) had second primary breast cancer, comprising 60.8% (228) synchronous and 39.2% (147) metachronous tumors. Regarding age, patients were predominantly in the ≥60 years age accounting for 39.9% (91) of synchronous and 48.3% (71) of metachronous cases, with a mean patient age of 55 years for synchronous and 59 years for metachronous tumors. Overall, 5-year survival in women with synchronous breast cancer was 86.5% (95%CI 79.69–91.21) and with metachronous cancer was 82.1% (95%CI 73.71–88.10), while 10-year survival was 69% for both synchronous and metachronous. Conclusion: There was no difference in overall survival of patients with second primary synchronous and metachronous at 5 and 10 years after treatment. However, in this cohort, we were not able to investigate the genetics profile to identify the presence of associated genetic syndromes, a factor that can modify our findings.
Style APA, Harvard, Vancouver, ISO itp.
3

Blebea, Nicoleta Mirela. "NUTRITIONAL THERAPY IN CLINICAL MANAGEMENT OF ONCOLOGICAL PATIENTS". W NORDSCI Conference Proceedings. Saima Consult Ltd, 2021. http://dx.doi.org/10.32008/nordsci2021/b1/v4/28.

Pełny tekst źródła
Streszczenie:
Nutritional therapy helps patients with cancer to maintain their weight within normal limits, maintain tissue integrity and reduce the side effects of cancer therapies. Nutritional oncology deals with both prevention and patient support during treatment, in convalescence and in palliative situations. Cancer patients need full support from the team of health professionals (oncologists, nurses and dietitians). The following basic elements should not be missing from the cancer patient's diet: water, protein intake, animal and vegetable fats, as well as vitamins and minerals. The diet of cancer patients should be closely monitored, as body weight should be kept within normal limits, ie a body mass index (BMI) between 19 and 24 (the calculation is made by dividing the weight by the square of the height). The oncologist should therefore be aware of the adverse effects of malnutrition on patient outcomes and view nutritional support as an essential component of the clinical management, chemotherapy, radiation therapy, antiemetic treatment, and treatment for pain.
Style APA, Harvard, Vancouver, ISO itp.
4

Sarmento, Carlos Eduardo, Daniel Guerra, Deborah Dantas, Emanuel Arnaud, Hallysson Santos, João Pedro Dias, Matheus Andrade i Alyson Souza. "POSTER: Dagda - A Virtual Reality Experience for Pediatric Patients with Cancer in Chemotherapy". W XXI Symposium on Virtual and Augmented Reality. Sociedade Brasileira de Computação - SBC, 2019. http://dx.doi.org/10.5753/svr_estendido.2019.8467.

Pełny tekst źródła
Streszczenie:
During the process of chemotherapy of pediatric patients with cancer, the discomfort proves to be one of the many challenges for the patient, intensified by the ease at which the child becomes upset or annoyed. As a form of distraction during part of the treatment, this poster proposes an application of virtual reality to mask the process, and additionally, allows for association within the cancer patient’s situation
Style APA, Harvard, Vancouver, ISO itp.
5

"Case series: Breast and ovarian cancer syndrome". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685364.

Pełny tekst źródła
Streszczenie:
Aims and Objectives: To report a series of cases with breast and ovarian carcinomas either in same patient or in a family and identifying the importance of BRCA 1, 2 genetic testing in such individuals. Materials and Methods: The medical records of breast and ovarian cancer patients operated over past 3 years at a single institute were reviewed retrospectively and their clinical profile, family history, final pathological reports and follow up data was collected. Results: 8 patients were found to have breast and ovarian malignancies, out of which 3 had synchronous breast and ovarian cancers, 4 had metachronous and 1 patient with ovarian cancer had history of breast cancer in family. Median age of presentation to the hospital was 47 years and median time interval in metachronous disease patients was 5.5 years. Conclusion: About 5% of people who have breast cancer and about 10% of women who have ovarian cancer have HBOC, caused by germline mutation in BRCA 1, 2 gene. These individuals have increased risk of developing breast cancer at younger age, TNBC, or developing a second primary in breast or ovary plus an overall risk of breast/ovarian/prostate/pancreatic malignancies in other family members due to inheritable mutation. Identification of BRCA mutation in such individuals can help family members to undergo genetic counseling and follow different screening and prevention guidelines from general population thus reducing the cancer risks.
Style APA, Harvard, Vancouver, ISO itp.
6

"Case series: Breast and ovarian cancer syndrome". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685348.

Pełny tekst źródła
Streszczenie:
Aims and Objectives: To report a series of cases with breast and ovarian carcinomas either in same patient or in a family and identifying the importance of BRCA 1,2 genetic testing in such individuals. Materials and Methods: The medical records of breast and ovarian cancer patients operated over past 3 years at a single institute were reviewed retrospectively and their clinical profile, family history, final pathological reports and follow up data was collected. Results: 8 patients were found to have breast and ovarian malignancies, out of which 3 had synchronous breast and ovarian cancers, 4 had metachronous and 1 patient with ovarian cancer had history of breast cancer in family. Median age of presentation to the hospital was 47 years and median time interval in metachronous disease patients was 5.5 years. Conclusion: About 5% of people who have breast cancer and about 10% of women who have ovarian cancer have HBOC, caused by germline mutation in BRCA1, 2 gene. These individuals have increased risk of developing breast cancer at younger age, TNBC, or developing a second primary in breast or ovary plus an overall risk of breast/ovarian/prostate/pancreatic malignancies in other family members due to inheritable mutation. Identification of BRCA mutation in such individuals can help family members to undergo genetic counseling and follow different screening and prevention guidelines from general population thus reducing the cancer risks.
Style APA, Harvard, Vancouver, ISO itp.
7

Lichtenfels, Martina, Carolina Malhone, Isabela Miranda, Ana Beatriz Falcone, Luiza Kobe, Fernanda Barbosa, Betina Vollbrecht i Antônio Luiz Frasson. "The influence of neoadjuvant chemotherapy response in local recurrence of breast cancer patients undergoing nipple-sparing mastectomy". W Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1063.

Pełny tekst źródła
Streszczenie:
Objective: Our study aimed to examine the influence of response to neoadjuvant chemotherapy (NACT) in local recurrence (LR) of o heterogeneous cohort of breast cancer patients who underwent nipple-sparing mastectomy (NSM) with immediate breast reconstruction. Methodology: We evaluated 101 breast cancer patients undergoing 194 NSM after NACT between January 2004 and December 2020. The data were retrospectively evaluated by the medical chart, and the patient’s follow-up was updated during the appointments. Results: The patient’s median age was 42.9 years. The majority of patients (90.2%) underwent bilateral procedures, and the reasons for the surgery in the contralateral breast were 18.8% diagnosis of high penetrance gene mutation, 4.9% breast cancer in both breasts, 2% atypia, and 74.3% asymmetry/ patient option. Breast reconstruction was performed using silicon prosthetic implants for 98 (97%) patients and with a tissue expander for only 3 (3%) patients. Luminal tumors were more prevalent (43.5%), followed by triple-negative (32.8%), luminal/HER2 (17.8%), and HER2 (5.9%). A complete response to NACT was observed in 23.5% of the patients, and 76.5% presented a partial response. In the mean follow-up of 50 months, 6 (5.9%) patients were diagnosed with LR as the first event, and achieving a partial response to NACT was not correlated to local relapse (p=0.5). When analyzing luminal and triple-negative tumors separately, we observed RPC in 9% of luminal and 36.5% of TN tumors, and all LRs occurred in patients with incomplete response. In luminal tumors with incomplete response to NACT was observed 2.5% of LR versus 9.5% in TN demonstrating an increased LR in triple-negative tumors without RPC to NACT. However, the statistical analysis did not demonstrate significance because of the small sample size. Conclusion: A complete response to NACT is associated with a better prognosis; however, in our mixed cohort, it does not interfere with the chance of developing LR. Further studies with more patients analyzing separately the breast cancer molecular subtypes are needed to verify this preliminary result.
Style APA, Harvard, Vancouver, ISO itp.
8

Jain, Vandana, Rupinder Sekhon, Shveta Giri i Sudhir Rawal. "Role of radical surgery in early stages of vaginal cancer". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685350.

Pełny tekst źródła
Streszczenie:
Objectives: The objective of our present study was to evaluate the efficacy of radical vaginectomy with or without radical hysterectomy in patients with FIGO stage I and II vaginal cancers. Materials and Methods: A retrospective study was carried out on 13 patients aged 35 – 78 years. All the patients underwent radical surgery for vaginal cancer from April 2010 till June 2015. Kaplan- meier analyses was used to calculate the disease free survival and overall survival at 12 months. Results: The mean age of patients was 54.9 years. Twelve patients were with FIGO stage I while one had stage II vaginal cancer. The histopathology was squamous cell cancer in 9 patients, small cell neuroendocrine cancer in two patients and malignant melanoma in 2 patients. The lesion was confined to upper 2/3 of vagina in 8 cases and lower 1/3 was involved in 5 cases. All the patients underwent radical surgery. Lymph node dissection was done in eleven patients out of whom lymph nodes were positive in 4 patients. Three patients had positive margins. Adjuvant treatment was given to patients with positive margins or positive nodes. Six patients did not require any adjuvant treatment and two patients defaulted adjuvant treatment. One patient developed Vesico-vaginal fistula. Over a follow up period ranging from 6 to 67 months, recurrence developed in two patients and one of them died of disease. The 12 months Disease free survival was 82.1% and 12 months Overall Survival was 90.9%. Conclusion: Stage I and selected stage II vaginal cancer patients have good outcomes in terms of survival and local tumor control if managed judiciously by initial surgery followed by selective adjuvant therapy.
Style APA, Harvard, Vancouver, ISO itp.
9

Liu, Ziyu, Wei Shao, Jie Zhang, Min Zhang i Kun Huang. "Transfer Learning via Optimal Transportation for Integrative Cancer Patient Stratification". W Thirtieth International Joint Conference on Artificial Intelligence {IJCAI-21}. California: International Joint Conferences on Artificial Intelligence Organization, 2021. http://dx.doi.org/10.24963/ijcai.2021/380.

Pełny tekst źródła
Streszczenie:
The Stratification of early-stage cancer patients for the prediction of clinical outcome is a challenging task since cancer is associated with various molecular aberrations. A single biomarker often cannot provide sufficient information to stratify early-stage patients effectively. Understanding the complex mechanism behind cancer development calls for exploiting biomarkers from multiple modalities of data such as histopathology images and genomic data. The integrative analysis of these biomarkers sheds light on cancer diagnosis, subtyping, and prognosis. Another difficulty is that labels for early-stage cancer patients are scarce and not reliable enough for predicting survival times. Given the fact that different cancer types share some commonalities, we explore if the knowledge learned from one cancer type can be utilized to improve prognosis accuracy for another cancer type. We propose a novel unsupervised multi-view transfer learning algorithm to simultaneously analyze multiple biomarkers in different cancer types. We integrate multiple views using non-negative matrix factorization and formulate the transfer learning model based on the Optimal Transport theory to align features of different cancer types. We evaluate the stratification performance on three early-stage cancers from the Cancer Genome Atlas (TCGA) project. Comparing with other benchmark methods, our framework achieves superior accuracy for patient outcome prediction.
Style APA, Harvard, Vancouver, ISO itp.
10

Shukla, H., K. Batra, R. Sekhon, S. Giri i S. Rawal. "Over view of clinical presentation, management and outcome of cervical cancer: A tertiary cancer centre experience". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685265.

Pełny tekst źródła
Streszczenie:
Objectives: (a) To understand the profile of cervical cancer patients attending our hospital from January 2011 till January 2015. (b) To audit the type of care given to the patients with respect to their stage at presentation. (c) To compare the outcomes of open v/s robotic radical hysterectomy done for cervical cancer. Methods: We prospectively analyzed all cases of cervical cancer from January 2011 to January 2015 presenting at our institute. Data was retrieved from patient’s records and institute’s tumor registry. We compared all patients undergoing open v/s robotic RH. All the data were analysed using SPSS version 21. Results: A total of 562 patients were treated for cervical cancer during the time period between 2011-2015. Of these there were 316 (56%) cases taken up for surgery-212 robotic RH, 104 open radical hysterectomy and rest 246 (44%) patients received definitive CCRT. Most common age group was 40-54 yrs. IB1 stage was most common presenting stage. SCC was most common histology (75%). Immediate post op complication and oncological safety in terms of local recurrence was same in both groups. However length of stay and post operative blood requirement was significantly lower in robotic RH group. 45% of all patients who underwent surgery did not require adjuvant therapy in post op period while 35% patient required post op RT and 20% CCRT. 2.2% patient had local recurrence and most of the patients were in stage IIA1 at presentation. Conclusion: Cervical cancer is the most common gynecological cancer in our hospital registry. Mostly women were in the age group of 40-54 years. Most common stage at presentation was 1B and the histology being SCC. Not many differences seen in open v/s robotic techniques of radical hysterectomy except for shorter hospital stay and less need of blood transfusion in the robotic group. Local recurrence rates are comparable in both open and robotic groups.
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Cancer patients"

1

Squiers, Linda, Mariam Siddiqui, Ishu Kataria, Preet K. Dhillon, Aastha Aggarwal, Carla Bann, Molly Lynch i Laura Nyblade. Perceived, Experienced, and Internalized Cancer Stigma: Perspectives of Cancer Patients and Caregivers in India. RTI Press, kwiecień 2021. http://dx.doi.org/10.3768/rtipress.2021.rr.0044.2104.

Pełny tekst źródła
Streszczenie:
Cancer stigma may lead to delayed diagnosis and treatment, especially in low- and middle-income countries. This exploratory, pilot study was conducted in India to explore the degree to which cancer stigma is perceived, experienced, and internalized among adults living with cancer and their primary caregivers. We conducted a survey of cancer patients and their caregivers in two Indian cities. The survey assessed perceived, experienced, and internalized stigma; demographic characteristics; patient cancer history; mental health; and social support. A purposive sample of 20 cancer survivor and caregiver dyads was drawn from an ongoing population-based cohort study. Overall, 85 percent of patients and 75 percent of caregivers reported experiencing some level (i.e., yes response to at least one of the items) of perceived, experienced, or internalized stigma. Both patients (85 percent) and caregivers (65 percent) perceived that community members hold at least one stigmatizing belief or attitude toward people with cancer. About 60 percent of patients reported experiencing stigma, and over one-third of patients and caregivers had internalized stigma. The findings indicate that fatalistic beliefs about cancer are prevalent, and basic education about cancer for the general public, patients, and caregivers is required. Cancer-related stigma in India should continue to be studied to determine and address its prevalence, root causes, and influence on achieving physical and mental health-related outcomes.
Style APA, Harvard, Vancouver, ISO itp.
2

Boyes, Allison, Jamie Bryant, Alix Hall i Elise Mansfield. Barriers and enablers for older people at risk of and/or living with cancer to accessing timely cancer screening, diagnosis and treatment. The Sax Institute, lipiec 2022. http://dx.doi.org/10.57022/ieoy3254.

Pełny tekst źródła
Streszczenie:
• Older adults have complex and unique needs that can influence how and when cancer is diagnosed, the types of treatment that are offered, how well treatment is tolerated and treatment outcomes. • This Evidence Check review identified 41 studies that specifically addressed barriers and enablers to cancer screening, diagnosis and treatment among adults aged 65 years and older. • Question 1: The main barriers for older people at risk of and/or living with cancer to access and participate in timely cancer screening relate to lack of knowledge, fear of cancer, negative beliefs about the consequences of cancer, and hygiene concerns in completing testing. The main enablers to participation in timely cancer screening include positive/helpful beliefs about screening, social influences that encourage participation and knowledge. • Question 2: The main barriers for older people at risk of and/or living with cancer to access and/or seek timely cancer diagnosis relate to lack of knowledge of the signs and symptoms of cancer that are distinct from existing conditions and ageing, healthcare accessibility difficulties, perceived inadequate clinical response from healthcare providers, and harmful patient beliefs about risk factors and signs of cancer. The main enablers to accessing and/or seeking a timely cancer diagnosis include knowledge of the signs and symptoms of cancer, and support from family and friends that encourage help-seeking for symptoms. • Question 3: The main barriers for older people at risk of and/or living with cancer in accessing and completing cancer treatment include discrimination against patients in the form of ageism, lack of knowledge, patient concern about the adverse effects of treatment, predominantly on their independence, healthcare accessibility difficulties including travel and financial burden, and patients’ caring responsibilities. The main enablers to accessing and completing cancer treatment are social support from peers in a similar situation, family and friends, the influence of healthcare providers, and involving patients in treatment decision making. • Implications. The development of strategies to address the inequity of cancer outcomes in people aged 65 years and older in NSW should consider: ­ Increasing community members’ and patients’ knowledge and awareness by providing written information and decision support tools from a trusted source ­ Reducing travel and financial burden by widely disseminating information about existing support schemes and expanding remote patient monitoring and telehealth ­ Improving social support by promoting peer support, and building the support capacity of family carers ­ Addressing ageism by supporting patients in decision making, and disseminating education initiatives about geriatric oncology to healthcare providers ­ Providing interdisciplinary geriatric oncology care by including a geriatrician as part of multidisciplinary teams and/or expanding geriatric oncology clinics.
Style APA, Harvard, Vancouver, ISO itp.
3

Dy, Sydney M., Arjun Gupta, Julie M. Waldfogel, Ritu Sharma, Allen Zhang, Josephine L. Feliciano, Ramy Sedhom i in. Interventions for Breathlessness in Patients With Advanced Cancer. Agency for Healthcare Research and Quality (AHRQ), listopad 2020. http://dx.doi.org/10.23970/ahrqepccer232.

Pełny tekst źródła
Streszczenie:
Objectives. To assess benefits and harms of nonpharmacological and pharmacological interventions for breathlessness in adults with advanced cancer. Data sources. We searched PubMed®, Embase®, CINAHL®, ISI Web of Science, and the Cochrane Central Register of Controlled Trials through early May 2020. Review methods. We included randomized controlled trials (RCTs) and observational studies with a comparison group evaluating benefits and/or harms, and cohort studies reporting harms. Two reviewers independently screened search results, serially abstracted data, assessed risk of bias, and graded strength of evidence (SOE) for key outcomes: breathlessness, anxiety, health-related quality of life, and exercise capacity. We performed meta-analyses when possible and calculated standardized mean differences (SMDs). Results. We included 48 RCTs and 2 retrospective cohort studies (4,029 patients). The most commonly reported cancer types were lung cancer and mesothelioma. The baseline level of breathlessness varied in severity. Several nonpharmacological interventions were effective for breathlessness, including fans (SMD -2.09 [95% confidence interval (CI) -3.81 to -0.37]) (SOE: moderate), bilevel ventilation (estimated slope difference -0.58 [95% CI -0.92 to -0.23]), acupressure/reflexology, and multicomponent nonpharmacological interventions (behavioral/psychoeducational combined with activity/rehabilitation and integrative medicine). For pharmacological interventions, opioids were not more effective than placebo (SOE: moderate) for improving breathlessness (SMD -0.14 [95% CI -0.47 to 0.18]) or exercise capacity (SOE: moderate); most studies were of exertional breathlessness. Different doses or routes of administration of opioids did not differ in effectiveness for breathlessness (SOE: low). Anxiolytics were not more effective than placebo for breathlessness (SOE: low). Evidence for other pharmacological interventions was limited. Opioids, bilevel ventilation, and activity/rehabilitation interventions had some harms compared to usual care. Conclusions. Some nonpharmacological interventions, including fans, acupressure/reflexology, multicomponent interventions, and bilevel ventilation, were effective for breathlessness in advanced cancer. Evidence did not support opioids or other pharmacological interventions within the limits of the identified studies. More research is needed on when the benefits of opioids may exceed harms for broader, longer term outcomes related to breathlessness in this population.
Style APA, Harvard, Vancouver, ISO itp.
4

Ying, Hongan, Jinfan Shao, Xijuan Xu, Wenfeng Yu i Weiwen Hong. Perineural Invasion is an Indication of Adjuvant Chemotherapy in Node Negative Colorectal cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, grudzień 2021. http://dx.doi.org/10.37766/inplasy2021.12.0103.

Pełny tekst źródła
Streszczenie:
Review question / Objective: Perineural invasion (PNI) is a possible route for metastatic spread in various cancer types, including colorectal cancer (CRC). PNI is linked to poor prognosis. For patients with lymph node positive colorectal cancer, a number of large-scale RCT studies have confirmed that they can benefit from chemotherapy, but there are still many controversies about whether colorectal patients with negative lymph nodes need adjuvant chemotherapy. At present, there is a general consensus that patients with stage II colorectal cancer who have risk factors such as PNI+ need chemotherapy. However, there are many recent literatures that show that patients with stage II colorectal cancer with nerve invasion risk factors can not prolong the OS and DFS of patients. At the same time, chemotherapy increases the toxicity, economic and mental burden of patients. Therefore, we hope to write this review to summarize the current research findings and provide some clinical guidance on whether patients with lymph node negative colon cancer who have perineural invasion should receive chemotherapy. Condition being studied: Patients with high-risk such as PNI+ stage II colon cancer (CC) are recommended to undergo adjuvant chemotherapy (ACT). However, whether such patients can benefit from ACT remains unclear. And recently studies shown that, ACT had no significant benefit among patients with PNI.
Style APA, Harvard, Vancouver, ISO itp.
5

Aziz, Md Abdul, Tahmina Akter i Mohammad Safiqul Islam. Effect of miR-196a2 rs11614913 polymorphism on cancer susceptibility: evidence from an updated meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0027.

Pełny tekst źródła
Streszczenie:
Review question / Objective: MiR-196a2 rs11614913 polymorphism has been studied in a wide range of cancers throughout the years. Despite a large number of epidemiological studies performed in almost all ethnic populations, the contribution of this polymorphism in cancer risk is still inconclusive. Therefore, this updated meta-analysis was performed to estimate a meticulous correlation between miR-196a2 rs11614913 variant and cancer susceptibility. Condition being studied: Different types of cancer patients and healthy controls were evaluated to detect the cancer risk in the individual case-control studies. We performed a meta analysis of these case control studies to get a pulled outcome risk.
Style APA, Harvard, Vancouver, ISO itp.
6

Novinger, Leah. Identification of Autoantibodies to Breast Cancer Antigens in Breast Cancer Patients. Fort Belvoir, VA: Defense Technical Information Center, październik 2011. http://dx.doi.org/10.21236/ada555908.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Wang, Yan, Wenpeng Song, Sicheng Zhou, Jie Tian, Yingxian Dong, Jue Li, Junke Chang i in. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients: a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To identify the risk of lung cancer in FHRC patients compared to the general population. Condition being studied: The incidence rate of lung cancer in women is obviously increasing over the past decade and previous evidence have indicated the significant relationship between disturbances in hormone levels and the risk of lung cancer. Therefore, we hypothesized female hormone-related cancer (FHRC), including the breast, endometrial, cervix, and ovary cancer, patients may experience a higher risk of developing subsequent lung cancer.
Style APA, Harvard, Vancouver, ISO itp.
8

Chang, Min Cheol, Yoo Jin Choo i Sohyun Kim. Effect of Prehabilitation in Colorectal Cancer Surgery: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2022. http://dx.doi.org/10.37766/inplasy2022.10.0015.

Pełny tekst źródła
Streszczenie:
Review question / Objective: Colorectal cancer increases with age, and elderly patients are associated with a poorer prognosis after colorectal surgery. Since comorbidity and frailty are associated with clinical outcomes, several strategies are introduced to improve clinical outcomes according to correct those.Despite efforts to improve the clinical outcome after surgery, patients with colorectal surgery still frequently experience complications. While Enhanced Recovery After Surgery has standardized principals, prehabilitation program varied among studies. The prehabilitation program according to the study showed differences in patient selection criteria, exercise, nutritional support, and methods of the outcome measurement. Therefore, various results have been reported regarding the effect of prehabilitation. The effectiveness of prehabilitation is still controversial. The aim of this study was to confirm the updated overall spectrum and measure the effect of prehabilitation in patients with colorectal cancer surgery.
Style APA, Harvard, Vancouver, ISO itp.
9

Zhang, Dan, Jingting Liu, Mengxia zheng, Chunyan Meng i Jianhua Liao. Prognostic and Clinicopathological significance of CD155 Expression in Cancer Patients: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0087.

Pełny tekst źródła
Streszczenie:
Review question / Objective: The present study aimed to comprehensively explore the relationship between CD155 expression and clinical characteristics and prognosis of cancer patients. The study was based on comprehensive search of relevant literature. In particular, the study attempted to define the role of CD155 in various cancer types. Eligibility criteria: The pre-established inclusion criteria were as follows: (1) all subjects were cancer patients who received standard treatment; (2) The expression of CD155 in the cancer patients was well-examined, and all patients were assigned into two groups based on the expression; (3) survival analysis was performed based on these two groups, and provided sufficient data to estimate the risk ratio (HR) and 95% confidence interval (CI) for overall survival (OS); and (4) scientific and reasonable research. Case reports, reviews, abstracts, letters, bioinformatic analysis, TCGA analysis, and articles that did not meet the inclusion criteria were excluded from analyses.
Style APA, Harvard, Vancouver, ISO itp.
10

Liu, JIe, Xu-li Yang, Xing Liu, Yan Xu i He-lang Huang. Predictors of readmission after pulmonary resection in patients with lung cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2022. http://dx.doi.org/10.37766/inplasy2022.10.0049.

Pełny tekst źródła
Streszczenie:
Review question / Objective: At present, risk factors for readmission after pulmonary resection in patients with lung cancer are still not fully elucidated, and related studies have shown inconclusive results. We conducted a meta-analysis of the existing literature with the aim of clarifying the risk factors for readmission and providing evidence for the prevention of readmission after surgical resection in patients with lung cancer. Eligibility criteria: Included articles needed to meet the following criteria: (I) the full article could be retrieved and had sufficient data for extraction; (II) the study focused on risk factors for readmission after pulmonary resection for lung cancer; and (III) patients were readmitted to the same institution. Studies were excluded if: (I) they were abstracts, letters, reviews, or case reports; (II) patients were readmitted to the emergency department or there was early return to the clinic; and (III) study contained repeated data or did not report the outcomes of interest.
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Cancer patients” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii